Internal Medicine and Psoriasis

Psoriasis is incurable, it responds well to many topical and systemic treatments. Cyclosporine may be used for severe, difficult-to-treat cases of widespread psoriasis. Improvement and results may be very rapid in onset. Major possible side effects include kidney and blood-pressure problems. Methotrexate is a common drug used for rheumatoid arthritis, and it has been used effectively for many years in psoriasis. The drug may cause liver and lung damage. Close physician monitoring and monthly to quarterly visits and labs are generally required.

  • Psoriasis and Cancer
  • Metabolic syndrome and psoriasis
  • Psoriasis and cardiovascular disease
  • Microbiome and Psoriasis

Related Conference of Internal Medicine and Psoriasis

April 26-27, 2024

8th International Congress on Dermatology

Barcelona, Spain
May 20-21, 2024

29th International Conference on Dermatology & Skin Care

Zurich, Switzerland
May 23-24, 2024

7th International Dermatology Conference: Skin and Body

Zurich, Switzerland
July 15-16, 2024

24th European Dermatology Congress

Paris, France
August 28-29, 2024

25th World Dermatology Congress

Paris, France
August 28-29, 2024

7th World Cosmetic and Dermatology Congress

Paris, France
September 16-17, 2024

14th International Conference on Cosmetology and Dermatology

Zurich, Switzerland
November 25-26, 2024

26th World Dermatology and Aesthetic Congress

Bali, Indonesia
December 02-03, 2024

7th International Dermatology and Cosmetology Congress

Prague, Czech Republic

Internal Medicine and Psoriasis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in